🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the efficacy and safety of PET regimen combi...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2017-03-01
Trial ID
NCT03273452
Treatments Being Tested
Primary objective of the study is to compare the efficacy of romidepsin whe...
Status
Completed
Location
ZNA Stuivenberg
Start Date
2013-01
Trial ID
NCT01796002
Treatments Being Tested
This study is a 52-week, randomized, open, active-controlled trial of patie...
Status
Unknown
Location
RenJi Hospital
Start Date
2017-09-07
Trial ID
NCT02936375
Treatments Being Tested
This is a phase 2 Study to investigate the safety, tolerability, and anti-t...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2023-08-03
Trial ID
NCT05963347
Treatments Being Tested
Study of T-PRED(TM) Compared to Pred Forte(R)...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2009-02
Trial ID
NCT00854061
Treatments Being Tested
Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2015-05
Trial ID
NCT02359162
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This phase II trial is studying how well giving SGN-30 together with combin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00365274
Treatments Being Tested
This study is designed to observed prospectively the efficacy and safety of...
Status
Completed
Location
Qilu Hospital
Start Date
2016-01-01
Trial ID
NCT03855007
Treatments Being Tested
AIM: To study the expression of CD4+CD25+ high regulatory T cells in periph...
Status
Completed
Location
Department of Ophthalmology, Xijing Hosptial
Start Date
2009-07
Trial ID
NCT01306474